6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine

C129H88Cl6F9N41O14 — CID 157064564

About 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine

6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine (PubChem CID 157064564) has the molecular formula C129H88Cl6F9N41O14 and a molecular weight of 2820.10 g/mol. Its IUPAC name is 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine.

Molecular Properties

• Compound Name: 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine
• PubChem CID: 157064564
• Molecular Formula: C129H88Cl6F9N41O14
• Molecular Weight: 2820.10 g/mol
• Exact Mass: 2815.54
• IUPAC Name: 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine
• SMILES: Clc1ccc(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)cc1.Clc1cccc(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)c1.FC(F)(F)c1ccc(Cl)c(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)c1.FC(F)(F)c1cccc(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)c1.Nc1cc(Oc2ccc(-c3nnc(Nc4cc(C(F)(F)F)ccc4Cl)o3)cc2)nc(N)n1.Nc1cc(Oc2ccc(-c3nnc(Nc4ccc(Cl)cc4)o3)cc2)nc(N)n1.Nc1cc(Oc2ccc(-c3nnc(Nc4cccc(Cl)c4)o3)cc2)nc(N)n1
• InChI: InChI=1S/C19H13ClF3N7O2.C19H11ClF3N5O2.C19H12F3N5O2.2C18H14ClN7O2.2C18H12ClN5O2/c20-12-6-3-10(19(21,22)23)7-13(12)26-18-30-29-16(32-18)9-1-4-11(5-2-9)31-15-8-14(24)27-17(25)28-15;20-15-6-3-12(19(21,22)23)7-16(15)26-18-28-27-17(30-18)11-1-4-13(5-2-11)29-14-8-24-10-25-9-14;20-19(21,22)13-2-1-3-14(8-13)25-18-27-26-17(29-18)12-4-6-15(7-5-12)28-16-9-23-11-24-10-16;19-11-3-5-12(6-4-11)22-18-26-25-16(28-18)10-1-7-13(8-2-10)27-15-9-14(20)23-17(21)24-15;19-11-2-1-3-12(8-11)22-18-26-25-16(28-18)10-4-6-13(7-5-10)27-15-9-14(20)23-17(21)24-15;19-13-3-5-14(6-4-13)22-18-24-23-17(26-18)12-1-7-15(8-2-12)25-16-9-20-11-21-10-16;19-13-2-1-3-14(8-13)22-18-24-23-17(26-18)12-4-6-15(7-5-12)25-16-9-20-11-21-10-16/h1-8H,(H,26,30)(H4,24,25,27,28);1-10H,(H,26,28);1-11H,(H,25,27);2*1-9H,(H,22,26)(H4,20,21,23,24);2*1-11H,(H,22,24)
• InChIKey: ABSLNCJVKPHNLA-UHFFFAOYSA-N
• XLogP: 32.91
• TPSA: 757.84 Ų
• H-Bond Donors: 13
• H-Bond Acceptors: 55
• Rotatable Bonds: 35
• Heavy Atoms: 199
• Complexity: —

Lipinski Rule of Five

4 violations

Rule	Value
MW ≤ 500	2820.10
LogP ≤ 5	32.91
H-Bond Donors ≤ 5	13
H-Bond Acceptors ≤ 10	55

Frequently Asked Questions

What is the IUPAC name of 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine?

The IUPAC name of 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine (CID 157064564) is 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine.

What is the SMILES notation for 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine?

The canonical SMILES for 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine is Clc1ccc(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)cc1.Clc1cccc(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)c1.FC(F)(F)c1ccc(Cl)c(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)c1.FC(F)(F)c1cccc(Nc2nnc(-c3ccc(Oc4cncnc4)cc3)o2)c1.Nc1cc(Oc2ccc(-c3nnc(Nc4cc(C(F)(F)F)ccc4Cl)o3)cc2)nc(N)n1.Nc1cc(Oc2ccc(-c3nnc(Nc4ccc(Cl)cc4)o3)cc2)nc(N)n1.Nc1cc(Oc2ccc(-c3nnc(Nc4cccc(Cl)c4)o3)cc2)nc(N)n1.

What is the InChIKey of 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine?

The InChIKey is ABSLNCJVKPHNLA-UHFFFAOYSA-N. The full InChI is InChI=1S/C19H13ClF3N7O2.C19H11ClF3N5O2.C19H12F3N5O2.2C18H14ClN7O2.2C18H12ClN5O2/c20-12-6-3-10(19(21,22)23)7-13(12)26-18-30-29-16(32-18)9-1-4-11(5-2-9)31-15-8-14(24)27-17(25)28-15;20-15-6-3-12(19(21,22)23)7-16(15)26-18-28-27-17(30-18)11-1-4-13(5-2-11)29-14-8-24-10-25-9-14;20-19(21,22)13-2-1-3-14(8-13)25-18-27-26-17(29-18)12-4-6-15(7-5-12)28-16-9-23-11-24-10-16;19-11-3-5-12(6-4-11)22-18-26-25-16(28-18)10-1-7-13(8-2-10)27-15-9-14(20)23-17(21)24-15;19-11-2-1-3-12(8-11)22-18-26-25-16(28-18)10-4-6-13(7-5-10)27-15-9-14(20)23-17(21)24-15;19-13-3-5-14(6-4-13)22-18-24-23-17(26-18)12-1-7-15(8-2-12)25-16-9-20-11-21-10-16;19-13-2-1-3-14(8-13)22-18-24-23-17(26-18)12-4-6-15(7-5-12)25-16-9-20-11-21-10-16/h1-8H,(H,26,30)(H4,24,25,27,28);1-10H,(H,26,28);1-11H,(H,25,27);2*1-9H,(H,22,26)(H4,20,21,23,24);2*1-11H,(H,22,24).

What are the key properties of 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine?

6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine has a molecular weight of 2820.10 g/mol, XLogP of 32.91, 35 rotatable bonds, 13 hydrogen bond donors, and 55 hydrogen bond acceptors.

Where does this data come from?

All data for 6-[4-[5-(3-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;6-[4-[5-(4-chloroanilino)-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-(3-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;N-(4-chlorophenyl)-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;6-[4-[5-[2-chloro-5-(trifluoromethyl)anilino]-1,3,4-oxadiazol-2-yl]phenoxy]pyrimidine-2,4-diamine;N-[2-chloro-5-(trifluoromethyl)phenyl]-5-(4-pyrimidin-5-yloxyphenyl)-1,3,4-oxadiazol-2-amine;5-(4-pyrimidin-5-yloxyphenyl)-N-[3-(trifluoromethyl)phenyl]-1,3,4-oxadiazol-2-amine is sourced from PubChem (CID 157064564), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).